Literature DB >> 15291875

The role of nitric oxide in bladder urothelial injury after bladder outlet obstruction.

Boris Chertin1, Udo Rolle, Valeria Solari, Salvatore Cascio, Prem Puri.   

Abstract

OBJECTIVE: To investigate the role of nitric oxide (NO) in the pathogenesis of injury to the bladder mucosa after bladder outlet obstruction (BOO).
MATERIALS AND METHODS: The response of bladder mucosa to BOO consists of thickening with fibrous connective tissue; NO is a multipurpose messenger important in blood vessel relaxation, neuronal communication and inflammatory activities of macrophages, and is synthesized by NO synthase (NOS), with three distinct isoforms; inducible (iNOS), endothelial (eNOS) and neuronal (nNOS). Fifteen male guinea pigs had a silk ligature placed around the bladder neck to induce BOO; controls included five sham-operated animals. The animals were killed at 2, 4, 6, 8 and 12 weeks after BOO. NADPH-diaphorase staining was used as a nonspecific method to determine NOS isoform distribution. Single- and double-label immunofluorescence histochemistry for iNOS, eNOS, nNOS and macrophage colony stimulating factor (M-CSF) were used, with laser scanning confocal microscopy to assess the results. The relative amount of iNOS mRNA was evaluated using reverse-transcription-polymerase chain reaction (RT-PCR), and a standard method to determine the degree of apoptosis.
RESULTS: Bladder mucosa had a markedly increased intensity of NADPH-diaphorase staining 2 weeks after BOO. iNOS immunoreactivity was markedly greater in the bladder mucosa 2 weeks after BOO than in controls. The immunolocalization of iNOS and M-CSF was identical in bladder mucosa after BOO. RT-PCR showed stronger iNOS mRNA expression in the obstructed bladder mucosa 2 weeks after BOO than in controls. eNOS and nNOS expression was detected only 8 weeks after BOO, with markedly more immunoreactivity 12 weeks after initiating BOO. Increased eNOS and nNOS immunoreactivity strongly correlated with the induction of apoptosis in the bladder mucosa.
CONCLUSION: There was overexpression of iNOS by activated macrophages in the early stages of BOO. This overexpression did not induce apoptosis in the iNOS-expressing cells of bladder mucosa in the early stages. After long-term BOO bladder mucosa showed strong eNOS and nNOS immunoreactivity, correlating with apoptosis. Thus we suggest that eNOS and nNOS, by triggering cell death, may be important in eliminating hyperplastic urothelial cells, reflecting the plasticity of the bladder response to obstructive stimuli.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15291875     DOI: 10.1111/j.1464-410X.2004.04968.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

Review 1.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

2.  Pressure activates epidermal growth factor receptor leading to the induction of iNOS via NFkappaB and STAT3 in human proximal tubule cells.

Authors:  Nalini V Broadbelt; Jie Chen; Randi B Silver; Dix P Poppas; Diane Felsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

3.  Nitric Oxide Synthase is Necessary for Normal Urogenital Development.

Authors:  Christopher Bond; Omer Onur Cakir; Kevin T McVary; Carol A Podlasek
Journal:  Andrology (Los Angel)       Date:  2013-11-04

4.  Pharmacogenetic inhibition of lumbosacral sensory neurons alleviates visceral hypersensitivity in a mouse model of chronic pelvic pain.

Authors:  Alison Xiaoqiao Xie; Nao Iguchi; Taylor C Clarkson; Anna P Malykhina
Journal:  PLoS One       Date:  2022-01-25       Impact factor: 3.240

5.  Gene expression profiles during tissue remodeling following bladder outlet obstruction.

Authors:  Saya Ito; Takeshi Nomura; Takashi Ueda; Shogo Inui; Yukako Morioka; Hisashi Honjo; Ayako Fukui; Atsuko Fujihara; Fumiya Hongo; Osamu Ukimura
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.